143 related articles for article (PubMed ID: 25756575)
1. Takotsubo cardiomyopathy: Utility of cardiac magnetic resonance to stratify risk for sudden cardiac death.
Ghafoor A; Janardhanan R
Int J Cardiol; 2015 Apr; 184():492-493. PubMed ID: 25756575
[No Abstract] [Full Text] [Related]
2. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
[TBL] [Abstract][Full Text] [Related]
3. [Implantable cardioverter defibrillators in the prevention of sudden cardiac death].
Bockeria LA; Neminushchiy NM; Mikhaylichenko SI; Novichkov SA; Achkasov EE
Ter Arkh; 2017; 89(12):103-109. PubMed ID: 29411768
[TBL] [Abstract][Full Text] [Related]
4. Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed.
Villuendas R; Kadish AH
Prog Cardiovasc Dis; 2008; 51(2):128-34. PubMed ID: 18774012
[TBL] [Abstract][Full Text] [Related]
5. Athletes with implantable cardioverter defibrillators: can they return to competitive sports?
Prutkin JM; Ackerman MJ; Drezner JA
Heart; 2016 Jan; 102(2):93-4. PubMed ID: 26729607
[No Abstract] [Full Text] [Related]
6. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
[TBL] [Abstract][Full Text] [Related]
7. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
8. Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death.
Hourdain J; Clavel MA; Deharo JC; Asirvatham S; Avierinos JF; Habib G; Franceschi F; Probst V; Sadoul N; Martins R; Leclercq C; Chauvin M; Pasquie JL; Maury P; Laurent G; Ackerman M; Hodge DO; Enriquez-Sarano M
Circulation; 2018 Sep; 138(10):1067-1069. PubMed ID: 30354542
[No Abstract] [Full Text] [Related]
9. Prolonged sustained ventricular fibrillation in a patient with dextrocardia and a left ventricular assist device.
Bolzan B; Morani G; Tomei R; Tomasi L; Borio G; Ribichini FL
J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):721-724. PubMed ID: 31389822
[No Abstract] [Full Text] [Related]
10. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
Gerstenfeld EP
J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
[No Abstract] [Full Text] [Related]
11. Myocardial Fibrosis as a Pathway of Prediction of Ventricular Arrhythmias and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy.
Centurión OA; Alderete JF; Torales JM; García LB; Scavenius KE; Miño LM
Crit Pathw Cardiol; 2019 Jun; 18(2):89-97. PubMed ID: 31094736
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification and primary prevention of sudden cardiac death: sudden death prevention.
Obias-Manno D; Wijetunga M
AACN Clin Issues; 2004; 15(3):404-18. PubMed ID: 15475814
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score.
Todiere G; Nugara C; Gentile G; Negri F; Bianco F; Falletta C; Novo G; Di Bella G; De Caterina R; Zachara E; Re F; Clemenza F; Sinagra G; Emdin M; Aquaro GD
Am J Cardiol; 2019 Oct; 124(8):1286-1292. PubMed ID: 31447011
[TBL] [Abstract][Full Text] [Related]
14. Antitachycardia pacing therapy for the successful treatment of lead fracture.
Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
[No Abstract] [Full Text] [Related]
15. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing.
Maass AH; Van Gelder IC
Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457
[No Abstract] [Full Text] [Related]
16. Normal blood catecholamines, recurrent ventricular fibrillation, and "ventricular scar", in a patient with Takotsubo syndrome.
Madias JE
Int J Cardiol; 2015 Apr; 185():248. PubMed ID: 25814210
[No Abstract] [Full Text] [Related]
17. Iron-Sensitive Cardiac Magnetic Resonance Imaging for Prediction of Ventricular Arrhythmia Risk in Patients With Chronic Myocardial Infarction: Early Evidence.
Cokic I; Kali A; Yang HJ; Yee R; Tang R; Tighiouart M; Wang X; Jackman WS; Chugh SS; White JA; Dharmakumar R
Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259581
[TBL] [Abstract][Full Text] [Related]
18. Aborted sudden cardiac death: ICD or no ICD.
Lachmann V; Makimoto H; Kelm M; Bönner F
Clin Res Cardiol; 2017 Sep; 106(9):760-763. PubMed ID: 28396986
[No Abstract] [Full Text] [Related]
19. Late Gadolinium Enhancement-Dispersion Mapping: A New Magnetic Resonance Imaging Technique to Assess Prognosis in Patients With Hypertrophic Cardiomyopathy and Low-Intermediate 5-Year Risk of Sudden Death.
Aquaro GD; Grigoratos C; Bracco A; Proclemer A; Todiere G; Martini N; Habtemicael YG; Carerj S; Sinagra G; Di Bella G
Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010489. PubMed ID: 32539460
[TBL] [Abstract][Full Text] [Related]
20. Sudden cardiac death secondary to demonstrated reperfusion ventricular fibrillation in a woman with Takotsubo cardiomyopathy.
Pepe M; Zanna D; Quagliara D; Caiati C; Marzullo A; Palmiotto AI; Caruso G; Favale S
Cardiovasc Pathol; 2011; 20(4):254-7. PubMed ID: 20705487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
